Most adults with type 1 diabetes use between 0.4 and 1.0 units of insulin per kilogram of body weight each day, a range recommended across multiple clinical guidelines as the starting point for therapy.1PubMed Central. Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review For a person weighing about 70 kilograms (roughly 154 pounds), that translates to somewhere between 28 and 70 units per day. That spread is enormous, and the reason it is so wide has everything to do with the dozens of variables that shift insulin needs up or down on any given day.
Why the Range Is So Wide
Saying “0.4 to 1.0 units per kilogram” sounds precise until you realize it can more than double from one end to the other. The range exists because insulin requirements depend on body composition, physical activity, residual pancreatic function, hormonal status, diet, and even the time of day. Two people with type 1 diabetes who weigh the same and eat the same meals can have strikingly different daily totals. Clinicians use the weight-based range as a starting estimate and then adjust based on blood-glucose patterns, making the “average” dose less of a fixed number and more of a moving target that shifts with life circumstances.
How the Daily Dose Splits Between Basal and Bolus
A total daily dose is divided into two broad categories: basal insulin, which covers background glucose production between meals and overnight, and bolus insulin, which covers the glucose spike after eating. The old clinical rule of thumb suggests a roughly even split, but real-world data tells a different story. In a study of patients on insulin pumps, the average basal portion was only about 24% of total daily insulin, with bolus doses making up the rest.2PubMed Central. Basal insulin requirement in patients with type 1 diabetes depends on the age and body mass index That skew makes sense when you think about it: in type 1 diabetes, the pancreas produces little to no insulin, so the body’s glucose regulation depends almost entirely on what you inject, and most glucose enters the blood after meals.
Interestingly, the 50-50 “rule” has been challenged even in type 2 diabetes. A study of over 300 patients with type 2 diabetes on stable blood-sugar control found that three-quarters of them actually used less than 50% of their total daily dose as basal insulin, and half used a basal fraction below about 41%.3PubMed Central. Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control If the old assumption overestimates basal needs even in type 2, where some natural insulin production remains, it tends to be even further off in type 1. The practical takeaway is that meal-time insulin usually accounts for the larger share of total daily insulin in most people with type 1 diabetes, and the split is something your care team fine-tunes over time rather than locking at 50-50.
The Honeymoon Phase and Residual Insulin Production
Shortly after diagnosis, many people with type 1 diabetes enter what clinicians call partial remission, or the “honeymoon phase.” During this window, the pancreas still secretes some insulin, which reduces the amount you need to inject. Blood-sugar levels can become surprisingly easy to manage, and daily insulin doses drop noticeably.4PubMed Central. Machine Learning-driven Identification of the Honeymoon Phase in Pediatric Type 1 Diabetes and Optimizing Insulin Management The honeymoon can last weeks to months, occasionally more than a year. It often leads newly diagnosed patients or their families to wonder if the diagnosis was wrong, because insulin needs can fall to a fraction of what was initially prescribed.
The honeymoon ends as the immune system continues destroying the remaining insulin-producing cells. When it does, daily insulin requirements climb to a new baseline that better reflects complete dependence on exogenous insulin. Recognizing this transition matters because under-dosing during the ramp-up can lead to poor glucose control and, in serious cases, diabetic ketoacidosis.
How Age and Puberty Change the Dose
Children and teenagers frequently need different doses per kilogram than adults, and much of that variation comes down to growth hormones. During puberty, rising levels of growth hormone and sex hormones create physiological insulin resistance, meaning the body’s cells respond less readily to insulin. Studies have confirmed that the stage of pubertal development correlates with higher daily insulin requirements per kilogram of body weight.5PubMed Central. Determinants and Characteristics of Insulin Dose Requirements in Children and Adolescents with New-Onset Type 1 Diabetes: Insights from the INSENODIAB Study It is not unusual for a teenager in the middle of puberty to need doses that would seem high for an adult of the same weight. After puberty finishes, doses per kilogram often settle back down.
At the other end of the age spectrum, older adults may need lower doses. Kidney function declines gradually with age, and because the kidneys clear a portion of circulating insulin, reduced kidney function means insulin stays active in the body longer. Older adults are also more susceptible to hypoglycemia, so clinicians tend to be conservative when setting their doses. The relationship between aging kidneys and insulin clearance is one of those under-discussed reasons that an older person’s “average” dose can look quite different from a younger person’s.
Body Weight and Insulin Resistance in Type 1
Type 1 diabetes was once stereotyped as a disease of thin people, but overweight and obesity are increasingly common in this population. Carrying extra weight introduces insulin resistance on top of the autoimmune insulin deficiency, a combination sometimes informally called “double diabetes.” A cross-sectional study found that people with type 1 diabetes who were overweight or obese had significantly higher total daily insulin doses than those at a normal weight, with body mass index strongly correlated to total daily dose.6PubMed Central. The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study The extra resistance means more insulin is needed to achieve the same glucose-lowering effect, pushing daily totals well above what the standard weight-based formula would predict for someone at a healthy weight.
This is one reason that two adults who both weigh 80 kg can have very different insulin needs. If one is muscular and active while the other has significant visceral fat, the second person’s cells respond less efficiently to insulin, requiring higher doses. Weight management in type 1 diabetes is challenging because insulin itself promotes fat storage, creating a feedback loop: higher doses to overcome resistance can promote further weight gain, which further raises resistance.
What You Eat Changes More Than the Bolus
Most people with type 1 diabetes learn carbohydrate counting early on, using their personal carbohydrate-to-insulin ratio to calculate how many units to take before each meal. A common starting formula divides 500 by the total daily dose to estimate how many grams of carbohydrate one unit of insulin covers. In practice, though, the actual ratio people use tends to differ from that estimate, and it varies by meal. A study of patients on insulin pumps found that the real ratio was about 11.5 grams per unit at breakfast, 12 at lunch, and 13.3 at dinner, while the formula predicted a flat 15.5 grams per unit across all meals.7PubMed Central. Carbohydrate-to-Insulin Ratio in a Mediterranean Population of Type 1 Diabetic Patients on Continuous Subcutaneous Insulin Infusion Therapy In other words, the formula underestimated how much insulin was actually needed, especially at breakfast, when insulin resistance is naturally higher.
Carbohydrates are not the only macronutrient that matters. Dietary fat also raises insulin needs. A controlled study comparing high-fat and low-fat dinners with identical carbohydrate content found that the high-fat meal required about 40% more insulin to cover it, and even with that extra insulin, blood sugar ran higher afterward.8PubMed Central. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes Protein has a similar, though usually smaller, delayed effect on blood glucose.9PubMed Central. Factors Beyond Carbohydrate to Consider When Determining Meantime Insulin Doses: Protein, Fat, Timing, and Technology A pizza with the same carb count as a bowl of rice will typically demand more insulin and a different timing strategy, which is something that simple carb-counting education does not always convey.
Exercise and Its Lingering Effects
Physical activity is one of the most powerful short-term modifiers of insulin needs, but its effects depend on the type of exercise. Aerobic exercise like running or cycling causes blood sugar to drop during the activity, which usually means you need to reduce bolus insulin for a preceding meal or have a snack. Resistance exercise like weightlifting behaves differently: it causes less of an immediate glucose drop during the session but produces more prolonged reductions in blood sugar afterward, sometimes lasting many hours into recovery.10PubMed Central. Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes
The practical consequence is that regular exercisers often have notably lower total daily insulin requirements than sedentary people of the same weight. Someone training for a marathon might see their daily total drop substantially, while a week off from training could push it back up. This variability catches people off guard because the effect is not limited to the hour of exercise itself; muscles continue pulling glucose from the blood for many hours as they replenish their energy stores. Basal insulin doses on highly active days often need to be reduced to prevent overnight lows.
The Dawn Phenomenon
Even within a single 24-hour period, insulin requirements are not flat. Most people with type 1 diabetes experience the “dawn phenomenon,” a rise in insulin needs during the early morning hours driven by the body’s natural release of hormones like cortisol and growth hormone. In a study of 114 people with type 1 diabetes, insulin requirements increased by roughly 19% between the overnight nadir and the early-morning peak, and this pattern was present in the vast majority of participants.11Diabetologia. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity The magnitude of the dawn phenomenon varied from person to person and was inversely related to how long someone had been living with diabetes.
For people on insulin pumps, this is addressed by programming higher basal rates in the pre-dawn hours. For those on injections, the timing and type of long-acting insulin can be adjusted to provide more coverage during that window. Either way, ignoring the dawn phenomenon means waking up with elevated blood sugar despite good control the rest of the day, which is one of the more frustrating aspects of type 1 management.
Illness and Stress
When you get sick or are under significant physical or psychological stress, the body releases counter-regulatory hormones like cortisol and adrenaline that push blood sugar up. For someone without diabetes, the pancreas compensates by releasing more insulin. In type 1 diabetes, that compensation does not happen, so exogenous insulin doses often need to increase substantially during illness.12PubMed. Sick-day management in type 1 diabetes A common cold might nudge doses up modestly, while a serious infection with fever can double or even triple insulin needs temporarily. Sick-day management protocols typically advise more frequent blood-sugar checks and correction doses, with the understanding that insulin resistance can spike quickly and unpredictably during acute illness.
Emotional stress is subtler but real. Chronic work stress, sleep deprivation, and anxiety can all elevate cortisol persistently enough to raise average blood sugars and insulin requirements. These effects are harder to quantify in a clinical study than an acute infection, but most people living with type 1 diabetes learn through experience that stressful periods come with higher insulin needs.
Pregnancy and Insulin Demands
Pregnancy is one of the most dramatic modifiers of insulin dose in type 1 diabetes. Hormones produced by the placenta, particularly human placental lactogen, create progressive insulin resistance as the pregnancy advances. A study of women with type 1 diabetes on insulin pumps found that total insulin requirements per kilogram increased by over 42% from conception to delivery, with the steepest climb happening in the third trimester.13PubMed. Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump Bolus and basal needs both rose, though at somewhat different rates across trimesters.
After delivery, insulin requirements typically plummet within hours, sometimes dropping to levels lower than pre-pregnancy baselines, especially if the person is breastfeeding. This rapid swing is one reason that pregnant women with type 1 diabetes are managed closely by specialized teams. Getting the dose right during pregnancy matters enormously for both maternal and fetal health, and the “right” dose at 36 weeks can be double what it was at 12 weeks.
Menstrual Cycle Fluctuations
Hormonal shifts during the menstrual cycle can also affect insulin sensitivity, though the effects are more modest than pregnancy. Research has shown that insulin sensitivity drops during the luteal phase, the roughly two-week stretch between ovulation and the start of menstruation, compared to the early follicular phase that follows a period.14PubMed Central. Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D In that study, total daily insulin and carbohydrate intake did not change significantly across cycle phases, yet hyperglycemia was more common during the luteal phase, suggesting that the same dose simply worked less well.
For some women, the change is large enough to warrant adjusting basal rates by a unit or two during the second half of each cycle. Others barely notice. Tracking blood sugars alongside cycle phase for a few months can reveal whether this pattern is meaningful for a given individual. It is an underappreciated source of dose variability that rarely gets discussed in standard diabetes education.
Newer Therapies That May Reduce Insulin Needs
Insulin remains the cornerstone of type 1 diabetes treatment, but researchers have explored whether medications originally designed for type 2 diabetes can complement it. GLP-1 receptor agonists, a class of drugs that includes semaglutide and liraglutide, have been studied in people with type 1 diabetes. Most trials have reported a meaningful reduction in daily insulin dose, particularly in the bolus (mealtime) portion, along with some weight loss.15Medical Research Archives. Do GLP-1 receptor agonists have a place in the treatment of people with type 1 diabetes? These drugs are not approved for type 1 diabetes in most countries, and using them carries a risk of hypoglycemia and diabetic ketoacidosis that requires careful monitoring. Still, they represent an emerging tool that could change the calculus of “average” dosing in the future for some patients.
SGLT2 inhibitors, another class used in type 2 diabetes, have also been trialed in type 1 with mixed results. While they can lower glucose and reduce insulin needs, the elevated risk of ketoacidosis has limited their adoption. The broader point is that the average insulin dose is not fixed by biology alone; it is also shaped by the therapeutic tools available, and those tools are evolving.
How Insulin Delivery Technology Affects Dosing
The method by which insulin is delivered can itself influence total daily dose. People on insulin pumps can fine-tune basal delivery hour by hour, which often leads to tighter control with somewhat less total insulin than those on multiple daily injections, where a single shot of long-acting insulin provides a flatter profile that cannot be adjusted in real time. Automated insulin delivery systems, sometimes called hybrid closed-loop systems, take this further by using a continuous glucose monitor to adjust basal rates automatically every few minutes. These systems tend to reduce both highs and lows, and in some users, overall insulin use shifts as the algorithm makes micro-corrections that a human simply cannot replicate with manual dosing.
That said, the technology does not change the fundamental physiology: the body still needs roughly the same amount of insulin to process a given meal. What changes is efficiency. Less insulin is wasted on poorly timed boluses or flat overnight basals that overshoot during the early night and undershoot at dawn. For someone considering a pump or automated system, it is worth knowing that total daily dose may not change dramatically, but the distribution across the day often shifts in ways that improve time-in-range without more insulin.
How Insulin Formulations Have Evolved
The earliest commercial insulin was extracted from animal pancreases, primarily beef and pork, and its behavior in the body closely resembled that of human insulin despite small differences in amino acid structure.16Endocrine Reviews. The Evolution of Insulin and How it Informs Therapy and Treatment Choices The shift to recombinant human insulin in the 1980s and then to insulin analogs in the 1990s and 2000s changed the dosing landscape. Rapid-acting analogs like lispro and aspart allow bolus insulin to be taken right at the start of a meal instead of 30 minutes before, which changed dosing accuracy and timing. Ultra-long-acting analogs like degludec provide flatter, more predictable basal coverage than older formulations, which can reduce total daily insulin in some patients simply by eliminating peaks and troughs.
The formulation matters when interpreting what “average dose” means in any given study. A patient on an older intermediate-acting insulin like NPH, which peaks several hours after injection and can cause lows if meals are delayed, might need a different total daily dose than a patient on a modern flat-profile basal analog, even if their diabetes is otherwise identical. When reading published dose ranges, it is worth considering which era and which insulin types those numbers come from.